Corbio ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  4.3% 28.1% 18.5% 22.3% 19.0%  
Credit score (0-100)  49 2 7 3 6  
Credit rating  BBB B B B B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  340 135 -34.8 -35.5 -48.8  
EBITDA  340 135 -34.8 -35.5 -48.8  
EBIT  99.5 -285 -34.8 -35.5 -48.8  
Pre-tax profit (PTP)  92.1 -280.0 -26.9 -29.8 -44.8  
Net earnings  71.7 -218.4 -21.0 8.9 -31.6  
Pre-tax profit without non-rec. items  92.1 -280 -26.9 -29.8 -44.8  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  609 391 370 379 347  
Interest-bearing liabilities  0.0 6.3 6.3 6.3 6.3  
Balance sheet total (assets)  1,824 430 384 393 361  

Net Debt  -673 4.7 -6.7 -1.5 3.3  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  340 135 -34.8 -35.5 -48.8  
Gross profit growth  56.0% -60.1% 0.0% -2.0% -37.4%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,824 430 384 393 361  
Balance sheet change%  -71.9% -76.4% -10.7% 2.3% -8.0%  
Added value  339.5 135.4 -34.8 -35.5 -48.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -480 -840 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 -1.0 -2.0 -3.0 -4.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  29.3% -210.3% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  2.4% -24.5% -6.6% -7.6% -11.9%  
ROI %  3.2% -55.0% -6.9% -7.8% -12.1%  
ROE %  12.5% -43.7% -5.5% 2.4% -8.7%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  33.4% 90.9% 96.3% 96.4% 96.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -198.4% 3.5% 19.3% 4.1% -6.8%  
Gearing %  0.0% 1.6% 1.7% 1.7% 1.8%  
Net interest  0 0 0 0 0  
Financing costs %  0.3% 113.3% 1.5% 2.3% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.2 11.0 26.9 27.6 25.4  
Current Ratio  1.2 11.0 26.9 27.6 25.4  
Cash and cash equivalent  673.5 1.6 13.0 7.7 2.9  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  189.2 390.7 369.7 378.6 347.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0